CoChat

Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders

Sacco, Kristi A., Bannon, Katie L., George, Tony P. · 2004 · Journal of Psychopharmacology
Cited by 96

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Cigarette smoking rates in the American population are approximately 23%, whereas rates of smoking in clinical and population studies of individuals with neuropsychiatric disorders are typically two- to four-fold higher. Studies conducted in a variety of neuropsychiatric populations [e.g. attention-deficit hyperactivity disorder (ADHD), Alzheimer's disease, schizophrenia] have collectively suggested that nicotine may be efficacious in remediating selected cognitive deficits associated with these disorders, thus providing a framework for understanding the specific vulnerability of these patients to smoking initiation and maintenance. However, the specific gain in cognitive performance produced by nicotine administration in healthy subjects with normal cognitive function is less clear. This article reviews our current understanding of central nicotinic acetylcholine receptor (nAChRs) systems in normal and neuropsychiatric disease states and, specifically, their role with respect to cognitive dysfunction and clinical symptoms in several specific neuropsychiatric populations, including ADHD, Alzheimer's disease, Parkinson's disease, Tourette's Disorder, schizophrenia and affective disorders. The potential benefits of nicotinic agents for therapeutic use in neuropsychiatric disorders is discussed, as well as directions for further research in this area.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/026988110401800403

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 165

  1. AciernoR A, KilpatrickD G, ResnickH S, SaundersB E, BestC L (1996) Violent assault, posttraumatic stress disorder, and depression. Risk factors for cigarette use among adult women. Behav Modificat 20: 363-384 · DOI
  2. 10.1176/ajp.150.12.1856 · DOI · Paper page
  3. 10.2165/00002512-199711060-00004 · DOI
  4. 10.1038/sj.npp.1300265 · DOI
  5. 10.1016/S0166-2236(00)01716-1 · DOI · Paper page
  6. 10.1016/0091-3057(85)90139-X · DOI · Paper page
  7. 10.1212/WNL.30.8.839 · DOI
  8. 10.1080/02791072.1999.10471731 · DOI
  9. Beckham J C, 1995, Addict Behav, 20, 1, 10.1016/0306-4603(94)00037-Y · DOI
  10. 10.1002/jts.2490080308 · DOI
  11. 10.1016/S0306-4603(96)00071-8 · DOI · Paper page
  12. 10.1016/0304-3940(92)90179-B · DOI
  13. BosboomJ L, StoffersD, WoltersECh (2003) The role of acetylcholine and dopamine in dementia and psychosis in Parkinson's disease. J Neural Transm 65 (Suppl): 185-195 · DOI
  14. Breese C R, 1997, J Pharmacol Exp Ther, 282, 7, 10.1016/S0022-3565(24)36798-9 · DOI · Paper page
  15. 10.1016/S0893-133X(00)00121-4 · DOI · Paper page
  16. 10.1212/WNL.43.2.293 · DOI · Paper page
  17. 10.1001/archpsyc.56.12.1141 · DOI · Paper page
  18. 10.1016/S1353-8020(03)00028-2 · DOI
  19. 10.1007/BF02245195 · DOI
  20. Conners C K, 1996, Psychopharmacol Bull, 32, 67
  21. 10.1192/bjp.179.1.35 · DOI
  22. 10.1016/S0006-3223(00)01116-1 · DOI · Paper page
  23. CoyleJ, KershawP (2001) Galanthamine, a Cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease. Biol Psychiatry 49: 289-299 · DOI · Paper page
  24. 10.1176/ajp.155.11.1490 · DOI · Paper page
  25. 10.1080/14622200210141635 · DOI
  26. Delagarza V W, 2003, Am Family Phys, 68, 1365
  27. 10.1007/s002130050631 · DOI
  28. 10.1177/026988119901300106 · DOI
  29. DepatieL, DriscollG A, HolahanA-L. V, AtkinsonV, ThavundayilJ X, Ying KinN N, SamarthjiL (2002) Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Ncuropsychopharmacology 27: 1056-1070 · DOI · Paper page
  30. Donnelly Roberts D L, 1998, J Pharmacol Exp Ther, 285, 777, 10.1016/S0022-3565(24)37422-1 · DOI
  31. 10.1007/s002130100719 · DOI
  32. 10.1017/S0033291796003984 · DOI
  33. 10.1124/mol.64.6.1283 · DOI
  34. 10.1002/1531-8257(199911)14:6<1011::AID-MDS1016>3.0.CO;2-F · doi:10.1002/1531-8257(199911)14:6<1011::aid-mds1016>3.0.co;2-f
  35. 10.1007/BF02806011 · doi:10.1007/bf02806011
  36. 10.1016/S0091-3057(02)00711-6 · DOI
  37. 10.1016/S0893-133X(01)00257-3 · DOI · Paper page
  38. 10.1073/pnas.061369098 · DOI · Paper page
  39. 10.1007/BF02244882 · DOI
  40. 10.1007/BF02805972 · DOI · Paper page
  41. 10.1038/379733a0 · DOI · Paper page
  42. 10.1073/pnas.93.24.14065 · DOI · Paper page
  43. 10.1016/S0166-4328(00)00206-0 · DOI · Paper page
  44. 10.1046/j.1471-4159.1999.0721117.x · DOI · Paper page
  45. 10.1016/0091-3057(95)02063-2 · DOI
  46. 10.1016/j.tips.2003.11.003 · DOI · Paper page
  47. George T P, 2001, Psychiatr Times, 18, 39
  48. 10.1016/S0006-8993(98)00537-X · DOI · Paper page
  49. George T P, 2000, J Pharmacol Exp Ther, 295, 58, 10.1016/S0022-3565(24)38869-X · DOI
  50. 10.1016/S0893-133X(01)00296-2 · DOI · Paper page
  51. George T P, 2003, Meyer J M
  52. 10.1007/s002130050554 · DOI
  53. 10.1093/bmb/65.1.21 · DOI
  54. 10.1016/S0006-3223(99)00130-4 · DOI · Paper page
  55. 10.4088/JCP.v59n0503 · DOI
  56. 10.1212/WNL.52.1.115 · DOI · Paper page
  57. 10.1093/oxfordjournals.aje.a116960 · DOI · Paper page
  58. GreenM F, MarshallB D, WirshingW C, AmesD, MarderS R, McGurkS R, KernR S, MintzJ (1997) Does risperidone improve verbal working memory in schizophrenia?' Am J Psychiatry 154: 799-804 · DOI · Paper page
  59. 10.1007/BF02251289 · DOI · Paper page
  60. 10.1007/s00213-002-1005-6 · DOI · Paper page
  61. 10.1046/j.1471-4159.1996.67051953.x · DOI · Paper page
  62. 10.1016/S0899-3289(20)30005-5 · DOI
  63. HeishmanS J (1999) Behavioral and cognitive effects of smoking: relationship to nicotine addiction. Nicotine Tobacco Res 1 (Suppl 2): S143–S147 · DOI · Paper page
  64. HeishmanS J, HenningfieldJ E (2000) Tolernance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers. Psychopharmacology 152: 321-333 · DOI
  65. 10.1007/s002130050493 · DOI
  66. HoweM N, PriceI R (2001) Effects of transdermal nicotine on learning, memory, verbal fluency, concentration, and general health in a healthy sample at risk for dementia. Int Psychogeriatr 13: 465-475 · DOI
  67. HutchisonK E, NiauraR, SwiftR (2000) The effects of smoking high nicotine cigarettes on pre-pulse inhibition, startle latency, and subjective responses. Psychopharmacology (Berl) 150: 244-252 · DOI
  68. 10.1146/annurev.pu.10.050189.000555 · DOI
  69. JonesG M, SahakianB J, LevyR, WarbirtpmD M, GrayJ A (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108: 485-494 · DOI · Paper page
  70. Kelton M C, 2000, Brain Cognit, 43, 274
  71. 10.1016/S0306-4603(01)00266-0 · DOI
  72. KnottV, BosmanM, MahoneyC, IlivitskyV, QuirtK (1999) Transdermal nicotine: single dose effects on mood, EEG, performance, and event-related potentials. Pharmacol Biochem Behav 63: 253-261 · DOI
  73. 10.1159/000054957 · DOI
  74. 10.1007/s002130050109 · DOI
  75. KumariV, GrayJ A (1999) Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex. Psychopharmacology (Berl) 141: 11-15 · DOI
  76. 10.1007/s002130050360 · DOI
  77. 10.1001/jama.284.20.2606 · DOI · Paper page
  78. 10.1016/S0896-6273(02)01004-8 · DOI · Paper page
  79. 10.1007/BF02244994 · DOI
  80. 10.1080/14622200110050213 · DOI · Paper page
  81. 10.1001/archpsyc.59.12.1085 · DOI · Paper page
  82. 10.1007/BF02247415 · DOI · Paper page
  83. 10.1007/s002130050667 · DOI · Paper page
  84. 10.1007/BF02246285 · DOI
  85. 10.1016/S0893-133X(96)00018-8 · DOI · Paper page
  86. 10.1007/s002130050750 · DOI · Paper page
  87. 10.1016/S0926-6410(98)00044-5 · DOI
  88. 10.1037/1064-1297.9.1.83 · doi:10.1037/1064-1297.9.1.83 · Paper page
  89. LezakM D (1995) Neuropsychological assessment. Oxford University Press, New York, NY
  90. 10.1007/s002130051107 · DOI
  91. 10.1002/neu.10148 · DOI · Paper page
  92. McConville B J, 1991, Am J Psychiatry, 148, 793, 10.1176/ajp.148.6.793 · DOI
  93. 10.1016/0006-3223(92)90315-Q · DOI
  94. 10.1007/s002130100899 · DOI
  95. 10.1016/S0028-3932(98)00012-8 · DOI
  96. 10.1007/BF02247425 · DOI
  97. 10.1038/npp.1994.11 · DOI
  98. 10.2165/00002512-199711030-00005 · DOI · Paper page
  99. 10.1007/BF00174504 · DOI · Paper page
  100. 10.1080/14622299050011371 · DOI
  101. 10.1038/sj.npp.1300173 · DOI
  102. 10.1016/S0893-133X(97)00095-X · DOI
  103. 10.1016/S0165-1781(03)00022-2 · DOI
  104. 10.1016/S0893-133X(99)00098-6 · DOI
  105. 10.1124/mol.54.6.1132 · DOI · Paper page
  106. 10.3109/15622970309167951 · DOI
  107. ParrottA C, CraigD (1992) Cigarette smoking and nicotine gum (0, 2 and 4 mg): effects upon four visual attention tasks. Neuropsychobiology 25: 34-43 · DOI
  108. 10.1007/s004150050299 · DOI · Paper page
  109. 10.1080/1462220021000018425 · DOI · Paper page
  110. PerkinsK A, GrobeJ E, FonteC, GoettlerJ, CaggiulaA R, ReynoldsW A, StilerR L, ScierkaA, JacobR (1994) Chronic and acute tolerance to subjective, behavioral, and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 270:628–638 · DOI · Paper page
  111. 10.1007/BF00445565 · DOI
  112. Picciotto M R, 2003, Trends Pharmacol Sci, 23
  113. 10.1007/s002130050722 · DOI
  114. 10.1016/0306-4603(94)90058-2 · DOI
  115. 10.1300/J069v20n01_07 · DOI · Paper page
  116. 10.1016/0899-3289(95)90030-6 · DOI · Paper page
  117. 10.1046/j.1360-0443.2002.00117.x · DOI · Paper page
  118. 10.1007/BF02245662 · DOI
  119. 10.1017/S0317167100046321 · DOI
  120. RajputA, OffordK P, BeardC M, KurlandL T (1987) A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology 37: 226-232 · DOI · Paper page
  121. 10.1523/JNEUROSCI.22-21-09604.2002 · DOI
  122. 10.1007/s002210000407 · DOI · Paper page
  123. 10.1002/ana.410190502 · DOI · Paper page
  124. 10.1016/S0014-2999(02)01452-8 · DOI
  125. RustedJ M, CaufieldD, KingL, GoodeA (2000) Moving out of the laboratory: does nicotine improve everyday attention?' Behav Pharmacol 11: 621-629 · DOI · Paper page
  126. SaccoK A, TermineA, SeyalA A, DudasM M, VessicchioJ C, Krishnan-SarinS, JatlowP I, WexlerB E, GeorgeT P (2004) Nicotinic recepter mechanisms and neuropsychological functioning in schizophrenia: effects on spatial working memory and attention. Arch Gen Psychiatry, in press
  127. SahakianB, JonesG, LevyR, GrayJ, WarburtonD (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154: 797-800 · DOI · Paper page
  128. SakuraiY, KanazawaI (2002) Acute effects of cigarettes in non-deprived smokers on memory, calculation and executive functions. Hum Psychopharmacol 17: 369-373 · DOI
  129. Salin-Pascual R J, 1996, J Clin Psychiatry, 57, 387
  130. 10.1124/jpet.102.045773 · DOI · Paper page
  131. 10.1124/jpet.103.051912 · DOI
  132. 10.1016/S0006-3223(02)01342-2 · DOI
  133. 10.1007/BF02247722 · DOI
  134. 10.3109/15622970209150616 · DOI
  135. SilverA A, ShytleR D, SheehanK H, SheehanD V, RamosA, SanbergP R (2001b) Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder. J Am Acad Child Adolesc Psychiatry 40: 1103-1110 · DOI · Paper page
  136. SimonR (2002) Clinical neurology. McGraw Hill, New York
  137. 10.1016/S0893-133X(02)00324-X · DOI · Paper page
  138. Snaedal J J T, 1996, Dementia, 7, 47
  139. 10.1016/0376-8716(89)90090-2 · DOI
  140. SpencerT, BiedermanJ (2002) Non-stimulant treatment for attention-deficit/hyperactivity disorder. J Atten Disord 6 (Suppl): S109–S119 · DOI
  141. SpilichG J (1994) Cognitive benefits of nicotine: fact or fiction? Addiction 89: 141-142 · DOI
  142. 10.1007/BF02316865 · DOI
  143. 10.1176/ajp.155.8.1009 · DOI · Paper page
  144. 10.1007/s002130050573 · DOI · Paper page
  145. 10.1016/S0014-2999(99)00886-9 · DOI
  146. Suter T W, 1983, Activas Nervosa Superior, 25, 261
  147. 10.1177/026988119200600210 · DOI · Paper page
  148. 10.1016/S0278-5846(01)00194-4 · DOI
  149. 10.1176/appi.ajp.157.3.368 · DOI · Paper page
  150. 10.1080/10673220127912 · DOI · Paper page
  151. Vezina P, 1992, JPET, 261, 484, 10.1016/S0022-3565(25)11064-1 · DOI · Paper page
  152. VictorM (2001) Adams and Victor's principles of neurology, McGraw Hill, New York
  153. ViereggeA, SiebererM, JacobsH, HagenahJ M, ViereggeP (2001) Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study. Neurology 57: 1032-1035 · DOI
  154. 10.1159/000109692 · DOI · Paper page
  155. 10.1016/0091-3057(91)90109-F · DOI
  156. 10.1037/0894-4105.14.3.409 · DOI · Paper page
  157. Weiss M, 2003, Can Med Assoc J, 168, 715
  158. 10.1007/BF00432014 · DOI
  159. WestR, HajekP, FouldsJ, NilssonF, MayS, MeadowsA (2000) A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology 149: 198-202 · DOI · Paper page
  160. 10.1007/BF00432045 · DOI
  161. 10.1007/s002130050931 · DOI · Paper page
  162. 10.1016/0091-3057(95)00043-V · DOI · Paper page
  163. Yang Y K, 2002, Neuropsychpharmacology, 27, 684
  164. ZhaoL, KuoY-P, GeorgeA A, PengJ-H, PurandareM S, SchroederK M, LukasR J, WuJ (2003) Functional properties of homomeric, human alpha-7 nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line. J Pharmacol Exp Ther 305: 1132-1141 · DOI
  165. 10.1177/1073858402239588 · DOI

Cited by

See all 96

Metadata

Authors
Sacco, K. A., Bannon, K. L., & George, T. P.
Venue
Journal of Psychopharmacology
Published
2004-12
Volume
18
Issue
4
Pages
457-474
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2137395053
Cited by
96
References
30
FWCI
2.62
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. https://app.cochat.ai/papers/10.1177/026988110401800403
The paper
Sacco, K. A., Bannon, K. L., & George, T. P. (2004). Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. Journal of Psychopharmacology. https://doi.org/10.1177/026988110401800403

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.